Ignite Creation Date:
2024-05-05 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 9:43 AM
Study NCT ID:
NCT00604500
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2008-01-21
Brief Title:
A Patient Handling Study of Mometasone FuroateFormortoral Fumarate MFF Metered Dose Inhaler MDI With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease Study P04703AM1
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
An Open-Label Multi-Center Patient Handling Study of Mometasone FuroateFormoterol Fumarate MDI With an Integrated Dose Counter in Adolescent and Adult Subjects and Adult With Asthma or COPD
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This was an open-label multiple-dose study of mometasone furoateformoterol fumarate MFF metered dose inhaler MDI 10010 micrograms mcg twice daily BID 2 puffs of MFF MDI 505 mcg administered twice a day approximately 12 hours apart in participants 12 years of age or older with a diagnosis of persistent asthma or chronic obstructive pulmonary disease COPD of at least 12 months The primary purpose of the study was to evaluate the performance of the MFF MDI integrated dose counter under normal patient handling conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 3462123 | None | None | None |